MTOR and cancer: Pretreatment of cancer cells with the COX-2 inhibitor, EP4 antagonist or the mTOR inhibitor, significantly reduced the phosphorylation of AktS473 in Rictor immunoprecipitates from 8-CPT-2Me-cAMP stimulated cells (Figure 6).